{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:25:19Z","timestamp":1771554319915,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T00:00:00Z","timestamp":1214524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T00:00:00Z","timestamp":1214524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s12185-008-0119-y","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T02:23:30Z","timestamp":1214447010000},"page":"30-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes"],"prefix":"10.1007","volume":"88","author":[{"given":"Takahiro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kohgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Niitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiya","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,27]]},"reference":[{"key":"119_CR1","doi-asserted-by":"crossref","unstructured":"Kushner JP, Porter J, Olivieri N. Secondary iron overload. Hematology\/American Society of Hematology Education Program Book: American Society of Hematology; 2001.","DOI":"10.1182\/asheducation-2001.1.47"},{"key":"119_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/10408368309165764","volume":"19","author":"GD McLaren","year":"1983","unstructured":"McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19:205\u201366.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"119_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1600-0609.2007.00842.x","volume":"78","author":"M Takatoku","year":"2007","unstructured":"Takatoku M, Uchiyama T, Okamoto S, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity\/mortality. Eur J Haematol. 2007;78:487\u201394.","journal-title":"Eur J Haematol"},{"key":"119_CR4","unstructured":"Shashaty G, Frankewich R, Chakraborti T, et al. Deferasirox for the treatment of chronic iron overload in transfusional hemosiderosis. Oncology (Williston Park). 2006;20:1799\u2013806, 1811; discussion 1811\u20133, 1817."},{"key":"119_CR5","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","volume":"23","author":"L Malcovati","year":"2005","unstructured":"Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol. 2005;23:7594\u2013603.","journal-title":"J Clin Oncol"},{"key":"119_CR6","first-page":"18","volume":"19","author":"N Gattermann","year":"2005","unstructured":"Gattermann N, Porter J, Lopes L, Seymour J. Consensus statement on iron overload in myelodysplastic syndromes. Hematol Oncol Clin North Am. 2005;19:18\u201325.","journal-title":"Hematol Oncol Clin North Am"},{"key":"119_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1600-0609.2007.00840.x","volume":"78","author":"AA Di Tucci","year":"2007","unstructured":"Di Tucci AA, Murru R, Alberti D, Rabault B, Deplano S, Angelucci E. Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol. 2007;78:540\u201342.","journal-title":"Eur J Haematol"},{"key":"119_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1365-2141.1996.d01-1795.x","volume":"94","author":"PD Jensen","year":"1996","unstructured":"Jensen PD, Heickendorff L, Pedersen B, et al. The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol. 1996;94:288\u201399.","journal-title":"Br J Haematol"},{"key":"119_CR9","first-page":"873","volume":"91","author":"A Piga","year":"2006","unstructured":"Piga A, Galanello R, Forni GL, et al. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica. 2006;91:873\u201380.","journal-title":"Haematologica"},{"key":"119_CR10","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","volume":"107","author":"MD Cappellini","year":"2006","unstructured":"Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455\u201362.","journal-title":"Blood"},{"key":"119_CR11","doi-asserted-by":"crossref","unstructured":"Porter J, Vichinsky E, Rose C, et al. A phase II study with ICL670 (Exjade), a once-daily oral iron chelator, in patients with various transfusion-dependent anemias and iron overload. Blood. 2004;104:abstract 3193.","DOI":"10.1182\/blood.V104.11.3193.3193"},{"key":"119_CR12","first-page":"1286","volume":"87","author":"EP Alessandrino","year":"2002","unstructured":"Alessandrino EP, Amadori S, Barosi G, et al. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology. Haematologica. 2002;87:1286\u2013306.","journal-title":"Haematologica"},{"key":"119_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.03907.x","volume":"120","author":"D Bowen","year":"2003","unstructured":"Bowen D, Culligan D, Jowitt S, et al. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol. 2003;120:187\u2013200.","journal-title":"Br J Haematol"},{"key":"119_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.6004\/jnccn.2006.0010","volume":"4","author":"PL Greenberg","year":"2006","unstructured":"Greenberg PL, Baer MR, Bennett JM, et al. Myelodysplastic syndromes clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006;4:58\u201377.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-008-0119-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12185-008-0119-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:26:57Z","timestamp":1707740817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-008-0119-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,27]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0119-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,27]]},"assertion":[{"value":"30 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}